HPAPI Manufacturing: What Are Highly Potent APIs?
Highly potent active pharmaceutical ingredients (HPAPIs) are APIs that produce a strong biological effect at very low doses. That same strength makes them hazardous to handle. HPAPI manufacturing needs specialised containment, equipment and procedures to protect workers, prevent cross-contamination and keep the product safe.
This guide explains what HPAPIs are, why they matter in oncology, how they are manufactured safely, and what buyers should ask suppliers.
Key Takeaways
- HPAPIs are active at very low doses, and exposure to even tiny amounts can harm workers.
- Many oncology APIs are cytotoxic or highly potent.
- Safe HPAPI manufacturing relies on containment, dedicated or segregated areas, trained staff and validated cleaning.
- Buyers should ask how a supplier classifies potency, controls exposure and prevents cross-contamination.
- Â
Overview of the Process
For a typical synthetic API, the flow looks like this:
- Process design and route selection
- Raw material and starting material qualification
- Chemical synthesis through intermediates
- Isolation and purification
- Drying and size reduction
- Quality control testing
- Packaging, labelling and release
What Is an HPAPI?
There is no single universal definition. In industry, an API is usually treated as highly potent when it is active at a very low dose or has a very low occupational exposure limit (OEL). A commonly used guide is an OEL of around 10 micrograms per cubic metre of air or lower, though companies and regulators use different criteria and the classification is based on a toxicological assessment of each compound.
HPAPIs include certain cytotoxic agents, some hormones, and other compounds that act at very low doses.
Why HPAPIs Matter in Oncology
Many cancer medicines are designed to damage or block rapidly dividing cells, so they are highly potent by nature. That is why oncology APIs are the best-known HPAPI group. Not every oncology API is an HPAPI, but many require HPAPI-style controls.z
Occupational Exposure Bands
Many companies classify compounds into occupational exposure bands (OEBs), which group substances by hazard and set the level of containment required. The higher the band, the tighter the containment. The exact band system and limits vary by company, so ask a supplier how it classifies each product.
How HPAPIs Are Manufactured Safely
Containment
Containment means keeping the compound inside a controlled environment. Typical measures include:
- closed processing and contained transfer of powders
- isolators or other containment devices for weighing, charging and sampling
- ventilation with filtration and controlled air pressure
Facility design
- dedicated or well-segregated production areas and equipment
- air-handling systems that prevent air from carrying the compound to other areas
- controlled movement of people, materials and waste
People and procedures
- trained operators and protective equipment suited to the hazard
- written procedures for handling, spills and emergencies
- monitoring of exposure where required
Cleaning and waste
- validated cleaning to prevent carryover between products
- controlled deactivation and disposal of waste
Quality and GMP
HPAPIs must also meet normal API quality standards. Note that ICH Q7 focuses on product quality and does not cover personnel safety, so worker protection is addressed separately. See GMP in pharmaceutical manufacturing.
What Buyers Should Ask an HPAPI Supplier
- How do you classify the potency of this compound, and what is the basis?
- What containment measures are used for this product?
- Is production dedicated or segregated, and how is cross-contamination prevented?
- How is cleaning validated?
- How do you protect workers and manage waste?
- What GMP certification and inspection history do you have?
- What packaging, labelling and transport safety information do you provide, including the Safety Data Sheet?
For a broader checklist, see how to evaluate a pharmaceutical API supplier.
HPAPIs at Salvavidas Pharma
Salvavidas Pharma is a WHO-GMP certified pharmaceutical manufacturer and exporter based in Surat, Gujarat, India, with products including oncology APIs. See our oncology API manufacturer page.
Frequently Asked Questions
What does HPAPI stand for?
Highly potent active pharmaceutical ingredient.
Are all cytotoxic drugs HPAPIs?
Most cytotoxic APIs are treated as highly potent, but classification depends on the toxicological assessment of each compound.
Why is HPAPI manufacturing expensive?
Containment equipment, dedicated or segregated facilities, specialised training and validated cleaning all add cost.
Is an HPAPI dangerous to patients?
When made and used correctly, HPAPI medicines are safe and effective. The hazard is mainly to workers and to other products if contamination occurs.
Need oncology or potent APIs?
Contact our export team with your molecule, grade and quantity.